Clover Health Investments Corp
NASDAQ:CLOV
ROCE
Return on Capital Employed (ROCE) measures how efficiently a company uses its capital to generate profit. It shows how much net income is earned for each dollar of capital employed.
Return on Capital Employed (ROCE) measures how efficiently a company uses its capital to generate profit. It shows how much net income is earned for each dollar of capital employed.
Peer Comparison
| Country | Company | Market Cap | ROCE | ||
|---|---|---|---|---|---|
| US |
|
Clover Health Investments Corp
NASDAQ:CLOV
|
1B USD |
Loading...
|
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
262B USD |
Loading...
|
|
| US |
A
|
Anthem Inc
LSE:0HG8
|
86.9B USD |
Loading...
|
|
| US |
|
Elevance Health Inc
NYSE:ELV
|
76.2B USD |
Loading...
|
|
| US |
|
Humana Inc
NYSE:HUM
|
21.5B USD |
Loading...
|
|
| US |
|
Centene Corp
NYSE:CNC
|
19.6B USD |
Loading...
|
|
| US |
|
Molina Healthcare Inc
NYSE:MOH
|
6.7B USD |
Loading...
|
|
| US |
|
Healthequity Inc
NASDAQ:HQY
|
6.3B USD |
Loading...
|
|
| US |
M
|
Magellan Health Inc
F:MAH1
|
2.2B EUR |
Loading...
|
|
| US |
|
Progyny Inc
NASDAQ:PGNY
|
1.8B USD |
Loading...
|
|
| BR |
|
Odontoprev SA
BOVESPA:ODPV3
|
6.4B BRL |
Loading...
|
Market Distribution
| Min | -1 112 400% |
| 30th Percentile | -2.3% |
| Median | 5.3% |
| 70th Percentile | 11.8% |
| Max | 334 937.1% |
Other Profitability Ratios
Clover Health Investments Corp
Glance View
Clover Health Investments Corp. embarked on a mission to transform the healthcare landscape with its innovative approach as a next-generation Medicare Advantage insurer. Born out of the need to reduce inefficiencies and enhance care, Clover Health uses its proprietary technology platform, the Clover Assistant, to arm physicians with data-driven insights that facilitate informed decision-making at the point of care. By integrating technology with healthcare delivery, Clover targets not only the evident administrative wastage but also addresses the structural challenges faced by patients and providers alike. This unique integration of digital tools with a traditional insurance model sets Clover apart in an industry ripe for disruption. Revenue for Clover Health primarily comes from Medicare Advantage premiums, where it competes by offering cost-effective plans combined with improved service. The company augments its financial model through government reimbursements tied to patient outcomes and the quality of care. Central to this strategy is the effective use of data analytics to manage patient care, reduce medical costs, and improve customer satisfaction. This alignment of financial incentives—lowering costs while enhancing patient outcomes—fuels Clover’s growth narrative, positioning it as a key player in reshaping how Medicare Advantage operates at the intersection of technology and healthcare delivery.
See Also
ROCE is calculated by dividing the EBIT by the Avg Capital Employed.
The current ROCE for Clover Health Investments Corp is -15.5%, which is above its 3-year median of -36.2%.
Over the last 3 years, Clover Health Investments Corp’s ROCE has increased from -78.3% to -15.5%. During this period, it reached a low of -78.3% on Sep 30, 2022 and a high of -7% on Mar 31, 2025.